Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company’s full-year net loss…
Market News
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent pharmacy market by making healthcare…
TRxADE Health Inc (MEDS) Q3 2022 Earnings Call Transcript
TRxADE Health Inc (NASDAQ:MEDS) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Janet Huffman — Chief Financial Officer Suren Ajjarapu — Founder, Chairman and Chief Executive Officer…
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile, the company’s net loss narrowed…
ADVERTISEMENT
Market News
Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent pharmacies, allowing them to operate…
TRxADE HEALTH, Inc. (MEDS) Q2 2022 Earnings Call Transcript
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 earnings call dated Jul. 25, 2022 Corporate Participants: Janet Huffman — Chief Financial Officer Suren Ajjarapu — Chief Executive Officer Analysts: Allen…
TRxADE HEALTH, Inc. (MEDS) Q2 2022
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2022 Earnings Conference
Market News
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more efficiently. The company’s digital platform…
ADVERTISEMENT
TRxADE HEALTH Inc. (MEDS) Q1 2022 Earnings Call Transcript
TRxADE HEALTH Inc. (NASDAQ: MEDS) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Janet Huffman — Chief Financial Officer Suren Ajjarapu — Founder, Chairman and Chief Executive…
AlphaGraphs
Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens
Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a wider net loss for the first quarter of 2022 despite a 6% increase in revenues.…